Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Assessing Feasibility of Thromboprophylaxis With Apixaban in JAK2-positive Myeloproliferative Neoplasm Patients

Ottawa Hospital Research Institute · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
myeloproliferative neoplasm (mpn), essential thrombocythemia (et), jak2 mutation, polycythemia vera (pv), primary myelofibrosis, venous thromboembolism (vte), interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 875294
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.